Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The requested name "Neomed Inovation" most likely refers to the NEOMED Institute and its NEOMED Innovation Centre in Québec, Canada, rather than to a standalone therapeutic biotech company with that exact spelling. NEOMED is a biomedical and translational research organization focused on advancing therapeutic and preventive medical solutions and supporting life-science commercialization. Its facilities include an open-access drug discovery and development hub in Montréal for small molecules and a Laval site focused on biologics and vaccines. Historically, the organization has also been described as bridging academic innovation and industry needs and developing programs to partnering-ready stages through its therapeutics activities. Based on publicly available information, it appears to function more as an innovation and translational R&D organization than as a classic single-asset clinical-stage biopharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neomed Inovation.